Menu Search
Equities

Blonder Tongue Laboratories Inc

BDRL:PKC

Blonder Tongue Laboratories Inc

Actions
  • Price (USD)0.0666
  • Today's Change-0.031 / -31.83%
  • Shares traded20.07k
  • 1 Year change-58.38%
  • Beta0.7089
Data delayed at least 15 minutes, as of Nov 12 2024 18:55 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Blonder Tongue Laboratories Inc had revenues fall -27.06% from 18.12m to 13.21m, though the company grew net income from a loss of 2.92m to a smaller loss of 2.12m.
Gross margin30.16%
Net profit margin-16.12%
Operating margin-11.77%
Return on assets-21.71%
Return on equity-134.02%
Return on investment-46.00%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Blonder Tongue Laboratories Inc fell by 71.00k. However, the company earned 1.99m from its operations for a Cash Flow Margin of 15.05%. In addition the company used 647.00k on investing activities and also paid 1.41m in financing cash flows.
Cash flow per share-0.2105
Price/Cash flow per share--
Book value per share0.0805
Tangible book value per share-0.0122
More ▼

Balance sheet in USDView more

Blonder Tongue Laboratories Inc has a Debt to Total Capital ratio of 85.11%, a higher figure than the previous year's 47.85%.
Current ratio0.977
Quick ratio0.4906
Total debt/total equity5.72
Total debt/total capital0.8511
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.